Cysteinylated Albumin as a Potential Biomarker for the Progression of
Kidney Disease in Patients With Type 2 Diabetes.

Imafuku T, Watanabe H, Oniki K, Yoshida A, Kato H, Nakano T, Tokumaru
K, Fujita I, Arimura N, Maeda H, Sakamoto Y, Kondo N, Morita A,
Saruwatari J, Tanaka M, Matsushita K, WADA T, Fukagawa M, Otagiri M,
Fitzgerald ML, Jinnouchi H, Maruyama T.

Diabetes Care. 2021 Apr26:
dc203003. doi: 10.2337/dc20-3003. Online ahead of print.